Pharmacotherapy in pediatric sleep disorders

Adolescent Medicine: State of the Art Reviews

Volumn 21, Issue 3, 2010, Pages 508-521

  Weiss, Shelly K ^a   Garbutt, Andrea ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856264209     PISSN: 19344287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Chambers C, Corkum P, Rusak B. The importance of sleep in pediatric chronic pain - A wake-up call for pediatric psychologists. J Pediatr Psychol. 2008;33(3):333-334
2. Corkum P, Panton R, Ironside S, Macpherson M, Williams T. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/ hyperactivity disorder. J Pediatr Psychol. 2008;33(4):368-379 (Pubitemid 351499461)
3. Limoges E, Mottron L, Bolduc C, Berthiaume C, Godbout R. Atypical sleep architecture and the autism phenotype. Brain. 2005;128(5):1049-1061 (Pubitemid 40675460)
4. Owens J. Classification and epidemiology of childhood sleep disorders. Sleep Med Clin. 2007; 2:353-361
5. Owens JA, Witmans M. Sleep problems. Curr Probl Pediatr Adolesc Health Care. 2004;34: 154-179 (Pubitemid 38444058)
6. Mindell J, Carskadon M, Owens J. Developmental features of sleep. In: Pfeffer C, Kaufman D, eds. Neurologic disorders: developmental and behavioural sequelae. Philadelphia: WB Saunders Company; 1999:695-725 (Pubitemid 29489262)
7. Owens JA, Babcock D, Blumer J, et al. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary. J Clin Sleep Med. 2005;1(1):49-59
8. Ounsted M, Hendrick A. The first-born child: patterns of development. Dev Med Child Neurol. 1977;19:446-453
9. Trott G, Badura F, Wirth S, et al. Self-assessment of prescribing behavior of psychotropic drugs for children and adolescents. Results of a survey of established physicians. Psychiatr Prax. 1995;22:235-239
10. Adams S. Prescribing of psychotropic drugs to children and adolescents. BMJ. 1991;302:217
11. Kopferschmitt J, Meyer P, Jaeger A, Mantz JM, Roos M. Sleep disorders and use of psychotropic drugs in 6-year-old children. Rev Epidemiol Sante Publique. 1992;20:467-471 (Pubitemid 23061087)
12. Patrois E, Valatx J, Alperovitch A. Prevalence of sleep and wakefulness disorders in high school students at the Academy of Lyon. Rev Epidemiol Sante Publique. 1993;41:383-388 (Pubitemid 23359222)
13. Ledoux S, Choquet M, Manfredi R. Self-reported use of drugs for sleep or distress among French adolescents. J Adolesc Health. 1994;15:495-502 (Pubitemid 24300268)
14. Owens J, Rosen C, Mindell J. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics. 2003;111(5 Pt 1):e628-e635
15. Stores G. Aspects of sleep disorders in children and adolescents. Dialogues Clin Neurosci. 2009;11:81-90
16. American Academy of Sleep Medicine. International classification of sleep disorders, revised: Diagnostic and coding manual. Chicago, IL: American Academy of Sleep Medicine; 2001
17. Mindell J, Emslie G, Blumer J, et al. Pharmacologic management of insomnia in children and adolescents: consensus statement Pediatrics. 2006;117(6):e1223-e1232 (Pubitemid 46071221)
18. Mindell J, Kuhn B, Lewin DS, et al. Behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep. 2006;29(10): 1263-1276 (Pubitemid 44571980)
19. Schnoes C, Kuhn BR, Workman EF, Ellis CR. Pediatric prescribing practices for clonidine and other pharmacologic agents for children with sleep disturbance. Clin Pediatr (Phila). 2006;45(3): 229-238 (Pubitemid 43788341)
20. Meltzer LJ, Mindell JA, Owens JA, Byars KC. Use of sleep medications in hospitalized pediatric patients. Pediatrics. 2007;119(6): 1047-1055 (Pubitemid 46871257)
21. Owens JA, Moturi S. Pharmacologic treatment of pediatric insomnia Child Adolesc Psychiatric Clin N Am. 2009;18:1001-1016
22. France K, Blampied N, Wilkinson P. A multiple-baseline, double-blind evaluation of the effects of trimeprazine tartrate on infant sleep disturbance. Exp Clin Psychopharmacol. 1999;7:502-513
23. Simonoff E, Stores G. Controlled trial of trimeprazine tartrate for night waking. Arch Dis Child. 1987;62:253-257 (Pubitemid 17056629)
24. Ottaviano S, Giannotti F, Cortesi F. The effect of niaprazine on some common sleep disorders in children: a double-blind clinical trial by means of continuous home-videorecorded sleep. Childs Nerv Syst. 1991;7:332-335
25. France K, Blampied N, Wilkinson P. Treatment of infant sleep disturbance by trimeprazine in combination with extinctioa J Dev Behav Pediatr. 1991;12:308-314
26. Montanari G, Schiaulini P, Covre A, Steffan A, Furlanut M, Niaprazine vs chlordesmethyldiazepam in sleep disturbances in pediatric outpatients. Pharmacol Res. 1992;25(Suppl 1):83-84
27. Russo R, Gururaj V, Allen J. The effectiveness of diphenhydramine HCL in pediatric sleep disorders. J Clin Pharmacol. 1976;16:284-288
28. Merenstein D, Diener-West M, Halbower AC, Krist A, Rubin HR. The trial of infant response to diphenhydramine: the TIRED study-a randomized, controlled, patient-oriented trial. Arch Pediatr Adolesc Med. 2006;160(7):707-712
29. Gringras P. When to use drugs to help sleep. Arch Dis Child. 2008;93(11):976-981
30. Ashton H. Guidelines for the rational use of benzodiazepines: when and what to use. Drugs. 1994;48(1):25-40
31. Pelayo R, Chen W, Monzon S, Guilleminault C. Pediatric sleep pharmacology: you want to give my kid sleeping pills? Pediatr Clin North Am. 2004;51:117-134 (Pubitemid 38121626)
32. Mindell J, Owens J. A clinical guide to pediatric sleep. Diagnosis and management of sleep problems, 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2010
33. Neubauer D. The evolution and development of insomnia pharmacotherapies. J Clin Sleep Med. 2007;3(5):S11-S15 (Pubitemid 47372574)
34. Blumer J, Reed MD, Steinberg F, et al. Potential pharmacokinetic basis for Zolpidem dosing in children with sleep difficulties. Clin Pharmacol Ther. 2008;83(4):551-558 (Pubitemid 351417057)
35. Stigler K, Posey D, McDougle C. Ramelteon for insomnia in two youths with autistic disorder. J Child Adolesc Psychopharmacol. 2006;16(5):631-636 (Pubitemid 44737216)
36. Pelayo R. Pediatric sleep pharmacology. Sem Pediatric Neurol. 2008;15:79-90 (Pubitemid 351794547)
37. Ingrassia A, Turk J. The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders: a case series. Eur Child Adolesc Psychiatry. 2005;14(1): 34-40
38. Prince J, Wilens TE, Biederman J, Spencer TJ, Wozniak JR. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996;35(5):599-605 (Pubitemid 26134797)
39. Wilens T, Biederman J, Spencer T. Clonidine for sleep disturbance associated with attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1994;33(3):424-426 (Pubitemid 24073285)
40. Sajith S, Clarke D. Melatonin and sleep disorders associated with intellectual disability: a clinical review. J Intellect Disabil Res. 2007;51(Pt 1):2-13 (Pubitemid 44869813)
41. Bendz L, Scates A. Melatonin treatment for insomnia in pediatric patients with attention-deficit/ hyperactivity disorder. Ann Pharmacother. 2010;44:185-190
42. Richdale A. Sleep disturbances in autism and Asperger's syndrome. In: Stores LWG, ed. Sleep disturbances in disorders of development. London: MacKeith Press; 2001:181-191
43. Smits M, Nagtegaal EE, van der Heijden J, Coenen AM, Kerkhof GA. Melatonin for chronic sleep onset insomnia in children: a randomized placebo controlled trial. J Child Neurol. 2001; 16:86-92 (Pubitemid 32390169)
44. Richdale A, Schreck K. Sleep problems in autism spectrum disorders: prevalence, nature and possible biopsychosocial aetiologies. Sleep Med Rev. 2009;13:403-411
45. O'Callaghan F, Clarke AA, Hancock E, Hunt A, Osborne JP. Use of melatonin to treat sleep disorders in tuberous sclerosis. Dev Med Child Neurol. 1999;41 (2): 123-126 (Pubitemid 29074079)
46. Leersnyder HD, Bresson JL, de Blois MC, et al. Beta 1-adrenergic antagonist and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. J Med Genet. 2003;40(1):74-78 (Pubitemid 36115131)
47. McArthur A, Budden S. Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol. 1998;40(3):186-192 (Pubitemid 28132696)
48. Braam W, Didden R, Smits MG, Curfs LM. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial. J Child Neurol. 2008;23(6):649-654 (Pubitemid 351720418)
49. Owens J, Rosen C, Mindell J. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians. Pediatrics. 2003;111:e628-e635
50. Owens JA, Moturi S. Pharmacologic treatment of pediatric insomnia. Child Adolesc Psychiatric Clin N Am. 2009;18:1001-1016
51. Pelayo R, Dubik M. Pediatric sleep pharmacology. Sem Pediatr Neurol. 2008;15:79-90 (Pubitemid 351794547)
52. Thorpy M. Therapeutic advances in narcolepsy. Sleep Med. 2007;8:427-440 (Pubitemid 46706356)
53. Bloomfield E. Parasomnias and movement disorders in children and adolescents. Child Adolesc Psychiatric Clin N Am. 2009;18:947-965
54. Guilleminault C, Palombini L, Pelayo R, Chervin RD. Sleepwalking and sleep terrors in prepubertal children: what triggers them? Pediatrics. 2003;111(1):e17-e25
55. Dolder C, Nelson M. Hypnosedative-induced complex behaviors: incidence, mechanisms and management. CNS Drugs. 2008;22(12):1021-1036
56. Mason T, Pack A. Pediatric parasomnias. Sleep. 2007,30(2): 141-151
57. Cortese S, Konofal E, Lecendreux M, et al. Restless legs syndrome and attention-deficit/ hyperactivity disorder: a review of the literature. Sleep. 2005;28(8):1007-1013 (Pubitemid 41170937)
58. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep. 1994;17:739-743
59. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lespérance P. Clinical, polysom-nographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12:61-65 (Pubitemid 27032881)
60. Allen R, Picchietti D, Hening WA, et al. Restless leg syndrome, diagnostic criteria, special considerations, and epidemiology. A report from the restless leg syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2): 101-119 (Pubitemid 36527231)
61. Connor J. Pathophysiology of restless legs syndrome: evidence for iron involvement. Curr Neurol Neurosci Rep. 2008;8(2): 162-166 (Pubitemid 351460250)
62. Connor J, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61(3):304-309 (Pubitemid 36975956)
63. Konofal E, Lecendreux M, Amulf I, Mouren MC. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004;158(12):1113-1115 (Pubitemid 39579170)
64. Simakajornboon N, Gozal D, Vlasic V, et al. Periodic limb movement in sleep and iron status in children. Sleep. 2003;26:735-738 (Pubitemid 39619785)
65. Simakajornboon N, Kheirandish-Gozal L, Gozal D. Diagnosis and management of restless legs syndrome in childrea Sleep Med Rev. 2009;13:149-156